Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Microencapsulation"
DOI: 10.1080/02652048.2017.1290155
Abstract: Abstract Bioavailability of oral drugs can be limited by an intestinal excretion process mediated by P-glycoprotein (P-gp). Polyethylene glycol (PEG) is a known P-gp inhibitor. Dispersion of Famotidine (a P-gp substrate) within PEGylated nanoparticles (NPs)…
read more here.
Keywords:
design peg;
nps prepared;
famotidine;
permeability ... See more keywords